Ayurvedic Medicines

All about Ayurveda

Flower

Information Filled Under ‘Medicines’ Category

Ayurvedic Medicine and Treatment Center in Indore

Ayurved is India’s ancient medicine practice and it helps cure many diseases with easy and widely available herbs and medicines.Indore has many good ayurved practitioners and doctors, as well as Ayurved hospitals are available in Indore.A One Ayurvedic CenterM S J House 17/1, Opp Trade Center, South Tukoganj, Indore – 452001Contact: 2422540, 9826051728 Akhand Aushadhi Bhandar13 Sitlamata Bazar, Indore – 452001Contact: 2545035 Amsar Pvt Ltd47 Fort Industrial Estate, Laxmi Bai Nagar, I

Excerpt from:
Ayurvedic Medicine and Treatment Center in Indore

GTR: Homes of the Future with Tom Schey of Minimal Productions

GreenTalk Radio host Sean Daily speaks with Tom Schey, President of Minimal Productions. Schey on building LEED Platinum certified, high-end green homes using minimalist architecture and SMART home design.

http://gtr.pod-ad.com/content/GTR/GTR_172_HomesFutureTomScheyMinimalProductions.mp3

Excerpt from:
GTR: Homes of the Future with Tom Schey of Minimal Productions

worlds first -Agriculture Yield Promoter

Dear Sirs, WIN-A-CROP is the worlds first -Agriculture Yield Promoter, i ncreases all Crops productivity by a minimum of 30% to 300% higher YIELDS. WIN-A-CROP is an absolutely safe & Eco-friendly 100% Organic Hi-Yield Promoter made with natural Plant extracts and Organics, based on latest research technology in Crop Functional-Nutrition and Plant productive sciences.

View post: 
worlds first -Agriculture Yield Promoter

Tactics vs. strategy in Pharma

Continuing on from my post the other day about Thinkers and Doers in Pharma , I was pleasantly surprised by the number of emails received and the offline debates that ensued, so a big thank you for all of you who engaged in the conversation, your perspectives and thoughts were much appreciated. This morning, several thoughts drifted my way during the Healthcare Social Media in Europe tweetup on Twitter, which you can find by searching for the #hcsmeu hashtag.  One of the questions covered by the organisers, @ andrewspong and @ whydotpharma was what are he differences between the EU and US in this space?  Perhaps rather than polarise things by region, I was thinking laterally about what is the difference between Pharma companies doing well with social media and those who are not?  Sometimes it comes down to that old chestnut: Strategy vs. Tactics.

Read more: 
Tactics vs. strategy in Pharma

Nerve Growth Factor: an interesting new treatment approach for glaucoma

A recent paper published in the Proceedings of the National Academy of Sciences   by scientists from the University of Rome has shown that the administration of nerve growth factor (NGF) stabilizes or reduces the damage to the optic nerve caused by the raised intra-ocular pressure (IOP) associated with glaucoma.  Glaucoma is an eye disease that is the world’s leading cause of blindness affecting 77 million people around the world and causes irreversible damage to vision.  An easy to use eye drop that stabilizes or reduces damage to retinal ganglion cells and the optic nerve cells offers exciting potential and is research that will be watched closely by companies with an ophthalmology portfolio. NGF was discovered by Stanley Cohen and Rita Levi-Montalcini, who received the 1986 Nobel Prize in Physiology.  NGF may have a neuroprotective and repair function within the body, which could explain its ability to stabilize nerve damage caused by raised IOP.  In the paper published by Bonini and Levi-Monalcini they administered eye drops with NGF to rats and three human subjects.  This caused an reduction in retinal ganglion cell death in the rats, and the patients who received NGF had improvements in their visual field and visual acuity.  The data is extremely promising, but in view of the small subject numbers and the fact that rat models do not always translate into humans, more extensive clinical trials data are needed to validate it as a potential new treatment.  Hopefully more data will be available for presentation at the ARVO (Association for Research in Vision and Ophthalmology) annual meeting in May next year.

Read more:
Nerve Growth Factor: an interesting new treatment approach for glaucoma

Thinkers and Doers in Pharma

One of the biggest challenges in the Pharma world is meshing strategy with execution in a timely and effective manner.  My experience in big Pharma taught me that the environment is often full of Thinkers, who sit on their 100,000 ft cloud plinking on their harps contemplating ideas, with little regard the practicalities of execution and Doers, who are focused on execution and chopping down trees, without necessarily asking if they are in the right forest or chopping down the right trees. It’s also the classic Global versus Affiliate wars, although not always

More here:
Thinkers and Doers in Pharma

Churg Strauss Syndrome – Ayurvedic Herbal Treatment

Churg-Strauss syndrome, also known as Allergic Angiitis and Allergic Granulomatosis, is a disorder caused due to inflammation in the blood vessels, leading to a reduced blood supply to organs and tissues, thereby causing a dysfunction of the organs or permanent damage. Asthma, allergic rhinitis, sinusitis, skin rash, fever, gastrointestinal bleeding, joint pains and swelling, pain, numbness and tingling in the hands and feet, and bleeding anywhere in the body, are common symptoms of this conditi

Original post:
Churg Strauss Syndrome – Ayurvedic Herbal Treatment

DOUBLE your Crop Yields & Income.

Dear Farmers, "WIN-A-CROP" Hi-Yield Promoter is the World’s latest 100% Organic product to DOUBLE the yields of Cotton, Chilies, Coconuts, all Fruits & Vegetables crops, Flower Crops, Seed Crops, Medicinal & Aromatic Crops. Simple foliar spray of water-soluble WIN-A-CROP , improves Soil fertility and Crops productivity, resulting in 100% and above higher yields in all Inorganic and Organic Cultures, fetching highest income to the Farmers and Corporate Cultivators.

More: 
DOUBLE your Crop Yields & Income.

Americans Spend Billions on CAM

In 2007, Americans spent nearly $34 billion out of pocket on complementary and alternative medicine (CAM), according to the National Health Interview Survey , (NHIS). CAM includes many different types of healthcare practices and products that are not generally considered to be conventional or allopathic medicine. The CAM component of this survey was developed by the National Center for Complementary and Alternative Medicine (NCCAM) and the Centers for Disease Control and Prevention’s National Center for Health Statistics (NCHS).

View original post here: 
Americans Spend Billions on CAM

Tracking brand activity in Pharma – the impact of the Onglyza approval

This morning I checked into my database intending to search for some information on lung cancer relating to the SATURN data in maintenance therapy that is being updated at the World Lung Congress in San Francisco. Instead, the first dozen items were on the FDA approval of Onglyza (saxagliptin).  Oooh.  It seems that the FDA just approved BMS/AZ’s joint development in diabetes, talk about a wealth of signalling data all at once.  This product is a me-too, very similar to Merck’s Januvia, a billion dollar therapy already on the market.  On checking my emails and Twitter alerts, there was a bunch of information pertaining to Onglyza, Januvia and also Lantus (insulin glargine), sanofi-aventis’ novel insulin product recently in the news for potential (but not proven) cancer adverse events

Originally posted here: 
Tracking brand activity in Pharma – the impact of the Onglyza approval

Signalling in Pharma – what is it?

Recently, I was talking with a Pharma client about signalling (or signaling as our American cousins call it) and how it can be extremely useful for marketing strategy purposes. We are all signalling our intent, ideas and thoughts everyday in our daily lives, but imagine if you can aggregate information about a company or brands strategic intent around future business events?  This might take the form of numerous sources including press releases, analyst presentations, discussions with company employees or physicians involved with clinical studies, news articles, RSS feeds, web2.0 tools, online search, social media monitoring etc.  In fact, you could look at the building of a picture about brand X or topic Y in a simple hub and spoke fashion like this:   Now imagine monitoring those sources over time and clearer, focused, sharper picture emerges about the strategic intent of the competition and if you’re aware of this intelligence, you can use it to your advantage by pre-empting defensive or offensive strategies as appropriate

Here is the original: 
Signalling in Pharma – what is it?

Cash for Clunkers Will Continue Despite Funds Drying Up

The Car Allowance Rebate System, aka “Cash for Clunkers”, has been a huge success!  Congress initially appropriated $1 billion dollars for this program that helps “consumers buy or lease a more environmentally-friendly vehicle from a participating dealer when they trade in a less fuel-efficient car or truck.”  The program was designed to [ Cash for Clunkers Will Continue Despite Funds Drying Up from Green Living Ideas ] Related Posts Beyond Hybrids: Green Auto Technology Hydrogen Fuel Cell Vehicles Alt Fuels Comparison

Go here to read the rest:
Cash for Clunkers Will Continue Despite Funds Drying Up

New Molecular Pathway For Targeting Cancer, Disease Discovered By UCLA Researchers

“Scientists found that by activating a receptor in cells called the liver X receptor (LXR), they were able to inhibit the hedgehog (Hh) signaling pathway, which is involved in the maintenance of tissue integrity and stem cell generation. When stimulated in an unregulated manner, however, the Hh pathway can also cause cancers of the brain, lung, blood, prostate, skin and other tissues. Blocking such unregulated stimulation of the Hh pathway had previously been shown in animal studies to prevent cancers, according to the researchers.

Read more from the original source: 
New Molecular Pathway For Targeting Cancer, Disease Discovered By UCLA Researchers

Expanded access clinical trials and market access

An interesting and useful way of providing cancer patients access to new drugs is to open clinical trials in expanded access programs, which are often smaller or stripped down versions of existing trials with less onerous monitoring compared to registration trials. The advantage of this type of program is that patients continue to gain access to treatments, oncologists gain experience in using the new therapies and there is the possibility to improve patient outcomes compared to standard of care or best supportive care if there are no other options available

More here: 
Expanded access clinical trials and market access

Loss of PTEN predicts Herceptin resistance

On the hot subject of biomarkers and predicting response to therapy, Scottish scientists at the Edinburgh Breakthrough Cancer Centre have made an important finding.  They have developed a new method for predicting a patient’s response to Herceptin.  Although trastuzumab targets HER-2, it does not benefit every woman who has HER-2+ breast cancer.  The puzzling question has long been why does resistance develop? The research group reported that they: “… Examined 122 samples of metastatic breast cancer tumours treated with Herceptin. They demonstrated that the amount of PTEN was related to overall survival and patients whose breast cancer tumours had high levels of PTEN survived on average 22 months longer than those with low levels.” In addition, using mathematical modeling techniques, the loss of PTEN was more predictive than could be determined using standard multivariate or laboratory analysis

Go here to see the original:
Loss of PTEN predicts Herceptin resistance

It’s Winter Gardening Time

If you are a gardener, your summer garden is probably in full swing.  You may be harvesting tomatoes, basil, onions, zucchinis, and even corn, but did you know it is time to plant your winter garden?  Winter gardening is my favorite, as I love cool weather crops and always feel like I Post from: Green Living Ideas It’s Winter Gardening Time Related Posts Companion Planting Techniques Going Green with Gardening Growing Your Garden This Spring Use Native Plants In Your Garden This Spring Agriculture of the Future: Japanese Plant Factories Methodically Produce Lettuce

Read more from the original source: 
It’s Winter Gardening Time

The Empire State Building Goes Green

It’s not just the people in America who are becoming energy efficient. Some of America’s most well known buildings are making the transition to green living. It’s probably just as well — the iconic structures of America, after all, set the example not just for the country, but for the rest of Post from: Green Living Ideas The Empire State Building Goes Green Related Posts Green Building/Remodeling Green Building and Sustainable Designs Green Living Ideas and Carlisle Wide Plank Floors Launch Green Building Center Energy Efficiency in Automotive and Building with Johnson Controls Green Roofs

Continued here: 
The Empire State Building Goes Green

Around the horn in Pharma

The last week or so has brought a variety of news in the Pharma world from good, bad to just plain old ugly.  BMS’s purchase of Medarex is an interesting one; time will tell what happens with the existing licensing deals and whether the pipeline, including ipilimumab pans out or not.  It certainly seems like shark infested waters at the moment, with an eat or be eaten strategy evolving in Pharma and Biotech. The other week we posted a snapshort of denosumab , a RANK-L inhibitor being tested for the treatment of breast cancer patients with bone mestastases.  Yesterday, Amgen announced a deal with GSK to promote the monoclonal antibody denosumab for postmenopausal osteoporosis (PMO) in Europe, Australia, New Zealand and Mexico once the product is approved.  Amgen will commercialize the drug for PMO and oncology in North America and for all oncology indications in Europe and specified markets.  Seems like a good deal at first sight – Amgen get increased commercialisation in areas where they are weak and GSK get to add another source of revenue in regions where they are strong

Here is the original: 
Around the horn in Pharma

Managing the news and information in Pharma

Someone raised an interesting question at a conference hosted by the Business Development Institute (#BDI) that I went to last week.  They asked how anyone could possibly keep up with all the Pharma news and information, never mind follow thousands of people and interact via social media? The answer is I don’t.  Obviously, we all dip in and snack sometimes, but for me, most of the time I aggregate my information sources and use it for intelligence purposes on demand, ie search.

Read the rest here:
Managing the news and information in Pharma

Louder Than Words: A Mother’s Journey in Healing Autism

Louder Than Words is about a mother’s determination to heal her child. Jenny McCarthy has done it again with another book you can’t put down. She writes like she’s talking to her best friend, inspiring the reader with stories of strong maternal instincts during the most trying time of her life

Read the original here:
Louder Than Words: A Mother’s Journey in Healing Autism

Herbal Sex Pills Are Natural Cures For Premature Ejaculation

A quick acclimatized blow for bootless acclamation can be as accessible as afire an herbal sex pill. Acclimatized herbal remedies access been acclimated auspiciously throughout time. The acclimatized accumulated of herbs and base extracts produces a able abominable enhancer that has the adequacy to arrest bootless ejaculation, cure arrect dysfunction or impotence, re-ignite abominable relationships, and restore abominable confidence

Here is the original post:
Herbal Sex Pills Are Natural Cures For Premature Ejaculation

Pharma shooting for the moon?

Given the recent glut of Pharma companies snapping up baby biotechs, you could well be wondering if some of them are betting the farm on the last roll of the dice or shooting for the moon like Apollo 11.  It’s a crapshoot though, as R&D offers no guarantees as the growing list of drugs failing in Phase III development over the last 12 months  shows. Is desperation starting to set in or should we be thinking that Pharma is now moving to Las Vegas from New Jersey?

See more here:
Pharma shooting for the moon?

Green MBA Programs Grow Up

tweetmeme_url=’http://greenlivingideas.com/topics/work-and-the-office/green-collar-jobs/green-mba-programs-grow-u’; tweetmeme_style = ‘normal’;tweetmeme_source = ‘greenlivingidea’; A need for green jobs has recently put into focus the need for advanced qualifications in sustainability and green business. While the corporate world focuses on devising strategies to address the business of sustainability, business schools across the country, are incorporating this relatively new field of Post from: Green Living Ideas Green MBA Programs Grow Up Green MBA Programs Grow Up Related Posts Environmental Engineering: How You Can Make an Impact How to Find a Green Job Green Jobs Climate Cycle: Chicago Rides Toward Solar Powered Schools Budget-Friendly Back-to-School Starter

See original here: 
Green MBA Programs Grow Up

Herbal Nutrition Supplement

Benefit of Herbal Nutrition Supplements for Your Life Herbal nutrition supplements – also known as food supplementation or dietary supplementation – are a preparation intended to provide nutrients such as vitamins, minerals and other nourishing substances that are deficient in a person’s diet. Nutritional supplemental products are intended to supplement a persons diet . Herbal nutrition supplement are also available from healthy direct together in a single supplement

See more here:
Herbal Nutrition Supplement

The challenge of social media in Pharma

Usually, I reserve Fridays for some random musings, humour, patient stories or some out of the box observations.  The end of the week needs some lighter relief as we all wind down. During yesterday’s #BDI conference on social media and Pharma, which was attended by over 350 people, someone put up this cartoon: You can find the original link here . It got the biggest laugh of day and resonated with any of us who have been Pharma marketers debating issues with the medical-regulatory-legal review team on just about any item.  That said, fortunately, I have been lucky enough in my career to work with some great review committees, staffed with excellent professionals, who were willing to work above and beyond as a team to get things done.  But what’s the difference between things going well or badly?  My simple answer is attitude.

More here: 
The challenge of social media in Pharma